Baseline Characteristics, n = 480 | Values |
---|---|
Age, yrs | 53 (13.3) |
Sex, male, n (%) | 135 (28.0) |
Symptom duration, mos, median (IQR) | 6.0 (3.0–17.8) |
VAS pain, median (IQR) | 52.0 (28.0–70.0) |
DAS28 | 4.8 (1.4) |
ESR, mm/h, median (IQR) | 20.0 (9.0–38.0) |
CRP, mg/l, median (IQR) | 7.5 (2.0–20.0) |
RF-positive, n (%) | 228 (50.9) |
ACPA-positive, n (%) | 256 (57.3) |
TJC 28, median (IQR) | 5.0 (2.0–9.0) |
SJC 28, median (IQR) | 5.0 (3.0–9.0) |
Conduction | |
Conduction disorder, n (%) | 60 (12.5) |
HR, bpm* | 66.7 (11.5) |
QRS, ms* | 93.8 (11.7) |
QT, ms* | 402.6 (30.7) |
QTc, ms* | 413.0 (17.2) |
PQ, ms* | 152.1 (23.7) |
Cardiovascular risk factors | |
Current smoking, n (%) | 154 (32.1) |
BMI, kg/m2 | 26.4 (4.9) |
Systolic BP, mmHg† | 134.1 (20.4) |
Diastolic BP, mmHg† | 80.1 (11.8) |
ABI† | 1.0 (0.1) |
TChol, mmol/l ‡ | 5.1 (1.0) |
Triglycerides, mmol/l, median (IQR) | 1.1 (0.8–1.5) |
LDL, mmol/l ‡ | 3.2 (0.9) |
HDL, mmol/l ‡ | 1.4 (0.4) |
TChol:HDL ratio ‡ | 4.0 (1.3) |
↵* Patients who did not use β-blockers, n = 455.
↵† Patients who did not use antihypertensive drugs, n = 360.
↵‡ Patients who did not use statins, n = 417. ABI: ankle brachial index; ACPA: anticitrullinated protein antibodies; BMI: body mass index; CRP: C-reactive protein; DAS28: 28-joint Disease Activity Score; BP: blood pressure; ESR: erythrocyte sedimentation rate; HDL: high-density lipoprotein; HR: heart rate; IQR: interquartile range; LDL: low-density lipoprotein; QTc: QT corrected for heart rate; RF: rheumatoid factor; SJC: swollen joint count; TChol: total cholesterol; TJC: tender joint count; VAS: visual analog scale.